|国家科技期刊平台
首页|期刊导航|影像科学与光化学|基于多模态影像学分析PCNS-DLBCL的临床表现及对预后的预测效能

基于多模态影像学分析PCNS-DLBCL的临床表现及对预后的预测效能OACSTPCD

Clinical Manifestations and Predictive Efficacy of Prognosis of PCNS-DLBCL Based on Multimodal Imaging Analysis

中文摘要英文摘要

目的:探究原发性中枢神经系统弥漫性大B细胞淋巴瘤(PCNS-DLBCL)的多模态影像学表现,并分析多模态影像学表现对预后的预测效能.方法:选取2020年8月至2022年12月我院收治的78例PCNS-DLBCL患者,统计分析多模态影像学检查结果,接受标准CHOP方案或利妥昔单克隆抗体联合标准CHOP方案(R-CHOP)作为一线治疗,化疗前均接受氟代脱氧葡萄糖正电子发射断层显像/计算机体层成像(18F-FDG PET/CT)检查,获取病灶总糖酵解值(TLG)、代谢肿瘤体积(MTV)、SUVpeak、SUVmax等参数,根据预后结果分为未进展组和进展组、生存组和死亡组,比较其两两之间的影像学参数,分析各参数对PCNS-DLBCL患者疾病进展、死亡预后的预测价值.结果:78例PCNS-DLBCL患者多模态影像学检查共发现192个病灶,33例为单发病灶(33个病灶),45例为多发病灶(159个病灶).单发病灶组、多发病灶组年龄、性别、病变分布、CT平扫、MRI T1WI、MRI T2WI、MRI 增强扫描、FLAIR 序列、MRS、DWI、FDG PET/CT 影像学表现比较,差异均无统计学意义(P>0.05),单发组握拳征、裂隙征占比高于多发组(P<0.05).随访1年,根据期间是否进展、是否存活分组,未进展组TLG、MTV、SUVpeak、SUVmax均低于进展组(P<0.05);生存组 TLG、MTV、SUVpeak、SUVmax 均低于死亡组(P<0.05);18F-FDG PET/CT各参数联合预测PCNS-DLBCL患者疾病进展、死亡的AUC分别为0.901、0.930,大于各参数单独预测的AUC.结论:PCNS-DLBCL单发、多发病灶多模态影像学表现无明显差异,不同疾病进展情况、生存情况患者18F-FDG PET/CT参数差异显著,TLG、MTV、SUVpeak、SUVmax对PCNS-DLBCL 患者疾病进展、死亡有较高预测价值.

Objective:To investigate the multimodal imaging presentation of primary central nervous system diffuse large B-cell lymphoma(PCNS-DLBCL)and to analyze the predictive efficacy of the multimodal imaging presentation on prognosis.Methods:78 patients with PCNS-DLBCL admitted to our hospital from August 2020 to December 2022 were selected and the results of multimodal imaging were statistically analyzed.Standard CHOP regimen or Rituximab combined with standard CHOP regimen(R-CHOP)were used as first-line treatment.All patients underwent fluorodeoxyglucose positron emission computed tomography(18F-FDG PET/CT)before chemotherapy to obtain the total lesion glycolysis(TLG),metabolic tumor volume(MTV),SUVpeak,SUVmax and other parameters.According to the prognosis results,the patients were divided into non-progression group and progressive group,survival group and death group.The imaging parameters between non-progression group and progressive group,survival group and death group were compared,and the predictive value of each parameter on disease progression and death prognosis of PCNS-DLBCL patients was analyzed.Results:A total of 192 lesions were detected in 78 patients with PCNS-DLBCL by multimodal imaging,33 cases were single lesions(33 lesions)and 45 cases were multiple lesions(159 lesions).There was no significant difference in age,sex,lesion distribution,CT plain scan,MRI T1WI,MRI T2WI,MRI enhanced scan,FLAIR sequence,MRS,DWI,FDG PET/CT imaging findings between the single lesion group and the multiple lesion group(P>0.05).The proportion of fist grip and fissure features in the single group was higher than that in the multiple group(P<0.05).At 1 year follow-up,TLG,MTV,SUVpeak and SUVmax were lower than the progression group according to the progression and survival groups(P<0.05).TLG,MTV,SUVpeak and SUVmax in the non-advanced group were lower than those in the advanced group(P<0.05).TLG,MTV,SUVpeak and SUVmax in survival group were lower than those in death group(P<0.05).The AUC of 18F-FDG PET/CT combined prediction of disease progression and death in PCNS-DLBCL patients was 0.901 and 0.930,respectively,which was greater than the AUC predicted by each parameter alone.Conclusion:There was no significant difference in the imaging findings of PCNS-DLBCL in single and multiple lesions.The 18F-FDG PET/CT parameters of patients with different disease progression and survival conditions were significantly different.TLG,MTV,SUVpeak and SUVmax have high predictive value for disease progression and death in PCNS-DLBCL patients.

陈玉珊;王璟;林洪;卢善良;詹阿来;陈少强

福建医科大学附属漳州市医院影像科,福建漳州 363000福建医科大学附属漳州市医院药学部,福建漳州 363000福建医科大学附属漳州市医院神经外科,福建漳州 363000福建医科大学基础医学院,福建福州 350100

临床医学

弥漫性大B细胞淋巴瘤中枢神经系统影像学PET/CT

diffuse large B-cell lymphomacentral nervous systemimagingPET/CT

《影像科学与光化学》 2024 (004)

327-335 / 9

2021年福建省自然科学基金联合资金新上项目(2021J011409)

10.7517/issn.1674-0475.2024.04.05

评论